Back
Kalaris Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
KLRS
Kalaris Therapeutics, Inc.
Last Price:
$9.95
Seasonality Move:
-37.32%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KLRS is experiencing selling pressure, which indicates risk of future bearish movement.
Kalaris Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.99 | Buy |
| 20-day SMA: | 7.29 | Buy |
| 50-day SMA: | 5.96 | Buy |
| 200-day SMA: | 5 | Buy |
| 8-day EMA: | 8.92 | Buy |
| 20-day EMA: | 7.71 | Buy |
| 50-day EMA: | 6.45 | Buy |
| 200-day EMA: | 6.7 | Buy |
Kalaris Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.07 | Buy |
| Relative Strength Index (14 RSI): | 64.62 | Buy |
| Chaikin Money Flow: | -207979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.58 - 8.56) | Buy |
| Bollinger Bands (100): | (3.22 - 6.82) | Buy |
Kalaris Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kalaris Therapeutics, Inc. Stock
Is Kalaris Therapeutics, Inc. Stock a Buy?
-
Kalaris Therapeutics, Inc. share price is 9.13 while KLRS 8-day simple moving average is 8.99, which is a Buy signal.
-
The stock price of KLRS is 9.13 while Kalaris Therapeutics, Inc. 20-day SMA is 7.29, which makes it a Buy.
-
Kalaris Therapeutics, Inc. 50-day simple moving average is 5.96 while KLRS share price is 9.13, making it a Buy technically.
-
KLRS stock price is 9.13 and Kalaris Therapeutics, Inc. 200-day simple moving average is 5.00, creating a Buy signal.
KLRS Technical Analysis vs Fundamental Analysis
Buy
61
Kalaris Therapeutics, Inc. (KLRS)
is a Buy
Is Kalaris Therapeutics, Inc. a Buy or a Sell?
-
Kalaris Therapeutics, Inc. stock is rated a BuyThe current Kalaris Therapeutics, Inc. [KLRS] share price is $9.13. The Score for KLRS is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Kalaris Therapeutics, Inc. Stock Info
Market Cap:
170.8M
Price in USD:
9.13
Share Volume:
251.6K
Kalaris Therapeutics, Inc. 52-Week Range
52-Week High:
12.90
52-Week Low:
2.14
Buy
61
Kalaris Therapeutics, Inc. (KLRS)
is a Buy
Kalaris Therapeutics, Inc. Share Price Forecast
-
What is the Kalaris Therapeutics, Inc. stock price today?The Kalaris Therapeutics, Inc. stock price is 9.13 USD today.
-
Will KLRS stock go up or go down?Kalaris Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Kalaris Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kalaris Therapeutics, Inc. is not overvalued.
Is Kalaris Therapeutics, Inc. Stock a Buy?
-
Kalaris Therapeutics, Inc. share price is 9.13 while KLRS 8-day exponential moving average is 8.92, which is a Buy signal.
-
The stock price of KLRS is 9.13 while Kalaris Therapeutics, Inc. 20-day EMA is 7.71, which makes it a Buy.
-
Kalaris Therapeutics, Inc. 50-day exponential moving average is 6.45 while KLRS share price is 9.13, making it a Buy technically.
-
KLRS stock price is 9.13 and Kalaris Therapeutics, Inc. 200-day simple moving average is 6.70, creating a Buy signal.
Fundamental Analysis of Kalaris Therapeutics, Inc.
Is Kalaris Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.35 per share.
Technical Analysis of Kalaris Therapeutics, Inc.
Should I short Kalaris Therapeutics, Inc. stock?
-
KLRS Moving Average Covergence Divergence (MACD) indicator is 1.07, suggesting Kalaris Therapeutics, Inc. is a Buy
-
Kalaris Therapeutics, Inc. Relative Strength Index (RSI) is 64.62, which suggest Kalaris Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Kalaris Therapeutics, Inc. is (5.58 - 8.56), which suggest Kalaris Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Kalaris Therapeutics, Inc. is (3.22 - 6.82), which suggest Kalaris Therapeutics, Inc. is a Buy
* Kalaris Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.